Susquehanna International Group’s IDEAYA Biosciences IDYA Stock Holding History

Susquehanna International Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.84M	Buy	115,200 +46,200	+67%	+$1.55M	﹤0.01%	4756
2025 Q4	$2.39M	Buy	69,000 +36,200	+110%	+$1.15M	﹤0.01%	5278
2025 Q3	$892K	Sell	32,800 -3,100	-9%	-$75K	﹤0.01%	7610
2025 Q2	$755K	Buy	+35,900	New	+$689K	﹤0.01%	8165
2024 Q4	–	Sell	-13,300	Closed	-$421K	–	12651
2024 Q3	$421K	Buy	13,300 +1,500	+13%	+$56.9K	﹤0.01%	8876
2024 Q2	$414K	Buy	11,800 +5,800	+97%	+$230K	﹤0.01%	8724
2024 Q1	$263K	Sell	6,000 -4,800	-44%	-$206K	﹤0.01%	10008
2023 Q4	$384K	Sell	10,800 -2,300	-18%	-$68.7K	﹤0.01%	9283
2023 Q3	$353K	Sell	13,100 -49,200	-79%	-$1.25M	﹤0.01%	9004
2023 Q2	$1.46M	Buy	+62,300	New	+$1.28M	﹤0.01%	5824
2021 Q1	–	Sell	-11,100	Closed	-$155K	–	12493
2020 Q4	$155K	Buy	+11,100	New	+$150K	﹤0.01%	10230

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Susquehanna International Group's IDYA Position: Q1 2026 in Review

Susquehanna International Group reduced its IDEAYA Biosciences (IDYA) stake by 27% in Q1 2026, selling an estimated $565K and leaving 46,709 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #6777.

Susquehanna International Group first reported a position in IDYA in Q4 2019 and has held it in 24 quarters since. The position peaked at $3.03M in Q2 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Susquehanna International Group held 46,709 shares of IDEAYA Biosciences worth $1.56M as of Q1 2026.
Susquehanna International Group sold 16,849 IDEAYA Biosciences shares in Q1 2026, an estimated $565K.
IDEAYA Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6777 holding.
Susquehanna International Group first reported a position in IDEAYA Biosciences in Q4 2019 and has held it in 24 quarters since.
Susquehanna International Group's IDEAYA Biosciences position peaked at $3.03M in Q2 2025.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.